Clinical Trial 21217

Pinellas Park, FL 33782


Summary:

A study to assess repeat treatment efficacy and safety of rifaximin 550 mg TID in subjects with irritable bowel syndrome with diarrhea (IBS-D).


Qualified Participants Must:

• Be 18 years of age or older
• Have been diagnosed with IBS-D
• Have had a colonoscopy within the last 2 years


Qualified Participants May Receive:

Up to $775.00


Clinical trials are medical research studies designed to test the safety and/or effectiveness of new investigational drugs, devices, or treatments in humans. These studies are conducted worldwide for a range of conditions and illnesses. Learn more about clinical research and participating in a study at About Clinical Trials.